SA

Sankarasubramanian Avudanayagam

Active Director Director DIN 02482326
DIN 02482326 First appointment Mar 2009 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Sankarasubramanian Avudanayagam

Data last updated:

Sankarasubramanian Avudanayagam is a Director at Krisan Pharmaceuticals Private Limited (since 2009). The company operates in Chemicals.

DIN 02482326
Primary Designation Director
Industry Chemicals
First Appointment 23 Mar 2009
Oldest Company Age 17 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Mar 20092009Active

Board colleagues of Sankarasubramanian Avudanayagam

NameDINCompanyDesignation
Leelavathy Sundaresan02535398Krisan Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Krisan Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sankarasubramanian Avudanayagam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sankarasubramanian Avudanayagam

Sankarasubramanian Avudanayagam currently holds 1 directorship: Krisan Pharmaceuticals Private Limited (Director, since 23 Mar 2009).

Sankarasubramanian Avudanayagam was first appointed on 23 Mar 2009 as Director at Krisan Pharmaceuticals Private Limited.

The current boards of Sankarasubramanian Avudanayagam's companies include Leelavathy Sundaresan (Krisan Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available